These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32122925)

  • 41. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.
    Shirai CL; Ley JN; White BS; Kim S; Tibbitts J; Shao J; Ndonwi M; Wadugu B; Duncavage EJ; Okeyo-Owuor T; Liu T; Griffith M; McGrath S; Magrini V; Fulton RS; Fronick C; O'Laughlin M; Graubert TA; Walter MJ
    Cancer Cell; 2015 May; 27(5):631-43. PubMed ID: 25965570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptome Profiling of Pediatric Core Binding Factor AML.
    Hsu CH; Nguyen C; Yan C; Ries RE; Chen QR; Hu Y; Ostronoff F; Stirewalt DL; Komatsoulis G; Levy S; Meerzaman D; Meshinchi S
    PLoS One; 2015; 10(9):e0138782. PubMed ID: 26397705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.
    Handschuh L; Wojciechowski P; Kazmierczak M; Marcinkowska-Swojak M; Luczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
    J Transl Med; 2018 Aug; 16(1):232. PubMed ID: 30126426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.
    Liang Y; Tebaldi T; Rejeski K; Joshi P; Stefani G; Taylor A; Song Y; Vasic R; Maziarz J; Balasubramanian K; Ardasheva A; Ding A; Quattrone A; Halene S
    Leukemia; 2018 Dec; 32(12):2659-2671. PubMed ID: 29858584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splicing factor mutations in hematologic malignancies.
    Chen S; Benbarche S; Abdel-Wahab O
    Blood; 2021 Aug; 138(8):599-612. PubMed ID: 34157091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.
    Damm F; Kosmider O; Gelsi-Boyer V; Renneville A; Carbuccia N; Hidalgo-Curtis C; Della Valle V; Couronné L; Scourzic L; Chesnais V; Guerci-Bresler A; Slama B; Beyne-Rauzy O; Schmidt-Tanguy A; Stamatoullas-Bastard A; Dreyfus F; Prébet T; de Botton S; Vey N; Morgan MA; Cross NC; Preudhomme C; Birnbaum D; Bernard OA; Fontenay M;
    Blood; 2012 Apr; 119(14):3211-8. PubMed ID: 22343920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TAP: a targeted clinical genomics pipeline for detecting transcript variants using RNA-seq data.
    Chiu R; Nip KM; Chu J; Birol I
    BMC Med Genomics; 2018 Sep; 11(1):79. PubMed ID: 30200994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
    Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML.
    Crews LA; Balaian L; Delos Santos NP; Leu HS; Court AC; Lazzari E; Sadarangani A; Zipeto MA; La Clair JJ; Villa R; Kulidjian A; Storb R; Morris SR; Ball ED; Burkart MD; Jamieson CHM
    Cell Stem Cell; 2016 Nov; 19(5):599-612. PubMed ID: 27570067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prognostic stratification in the treatment of AML].
    Asou N
    Rinsho Ketsueki; 2016; 57(10):1918-1927. PubMed ID: 27725589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia.
    Kivioja JL; Lopez Martí JM; Kumar A; Kontro M; Edgren H; Parsons A; Lundán T; Wolf M; Porkka K; Heckman CA
    Leuk Lymphoma; 2018 Mar; 59(3):725-732. PubMed ID: 28776436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

  • 54. Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia.
    Wang M; Lindberg J; Klevebring D; Nilsson C; Lehmann S; Grönberg H; Rantalainen M
    J Natl Cancer Inst; 2018 Oct; 110(10):1094-1101. PubMed ID: 29506270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phase.
    Hidalgo-Lopez JE; Kanagal-Shamanna R; Reyes S; Zhao C; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2019 Jun; 40():45-48. PubMed ID: 30928887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
    Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
    Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Study of SRSF1 Regulates Abnormal Alternative Splicing of BCL2L11 and the Role in Refractory Acute Myeloid Leukemia.
    Wang Q; Duan Y; Zan Z; Yang K; Wang J; Jia F; Tan Y; Wang H; Li L
    Chemotherapy; 2024; 69(4):224-236. PubMed ID: 38763139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins.
    Yoshimi A; Abdel-Wahab O
    Clin Cancer Res; 2017 Jan; 23(2):336-341. PubMed ID: 27836865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.